Correlation of mucormycosis with duration of steroid and oxygen therapy

Abstract

Introduction: Covid-19 patients have many complications after treatment, including fungal infection, disseminated intravascular coagulation, septicemia, cardiac problems, fissures, piles and meningitis. Out of these; Mucormycosis- A lethal fungal infection which is caused by the family of mucorcea; is more prevalent in post covid-19 patients. Mucormycosis is well correlated with post covid-19 infection; who underwent prolonged steroid & oxygen therapy during hospitalization. Mucormycosis is more common in covid-19 patients with immunocompromised status like Diabetes mellitus, Hypertension, cancer, organ transplant etc. Aims & objectives:(1) To correlate mucormycosis, a fungal infection in covid-19 patients with duration of steroid and oxygen therapy.(2) To correlate mucormycosis with various comorbidities & hospitalization. Materials&Method: All radiologically and histopathologically proven cases would be selected for our study. Complete clinical history of patients would be taken. Steroid and oxygen treatment given to the patient would be correlated.Type of study: Prospective & retrospective. Duration of study: 6 months Inclusion criteria: (1) Patients aged 18 years & above.(2) Patient with mucormycosis in covid-19 infection with or without hospitalization.(3)All radiologically suggested fungal infection in covid-19 induced pneumonia with active disease in recovery phase. Exclusion criteria: (1) Age less than 18 years. (2) Patients with incomplete clinical history. Conclusion: Mucormycosis is more common in hospitalized patients with prolonged steroid & oxygen therapy. We may prevent mucormycosis in covid-19 patients by reducing duration of steroid therapy.